They showed that similar methylations were detected in the serum of patients with aberrant methylation in the tumor tissues, but no methylated p16 sequences were detected in the peripheral serum of the patients with tumors without these methylation changes or in the healthy controls [39]. The gene discussed is CDKN2A; the disease is neoplasm.